This is an open letter to all large institutional investors with significant biotechnology/pharmaceutical experience.
The Company
Cel Sci Corp is a small, Immunology based biotech with a small pipeline outside of Multikine.
41 million shares outstanding with only State Street, BlackRock and Vanguard having ~5% stakes.
Extremely oversold with massive short shares outstanding and a significant presence keeping the price down, meaning they will short sell into a large ownership percent (as they already have done with State Street).
Theoretical end market capitalization of $15+ billion, possibility for setting record; No need to rely on acquisition, company can be shifted towards manufacturing and sales while keeping research pipeline in place as manufacturing facility already built and owned by company.
Multikine
Mix of cytokines and interleukins in a proprietary mix that is injected into primary and secondary tumour sites to activate the immune system, capable of activating through some form of immunoblockade, but plenty of room for advancement with existing and next wave immunoblockade inhibitors.
No adverse reactions with drug.
Given pre-surgery.
Nothing unique to Head and Neck Cancer, thus creating a possible market in all solid tumours; metastatic cancers unknown, but possible depending on immune cells activated, possible mechanism similar to "cancer vaccines", but with self-made antigens.
Massive market with possible repeat dosing, likely route to becoming SOC or routine additional medicine to all existing cancer therapeutic strategies.
Cures cancer and saves lives (increased survival >5 years over existing surgery+radiation, likely better effect over Cisplatin meaning less cisplatin use as frontline).
Best Theoretical Plan
Calls are dirt cheap, and all strike prices are going to be in the money post-catalyst (either FDA news or large scale investor, aka you).
Buy all the calls, buy batches of shares, 10k in size with time to cool between cycles as shorts will continue to try to suppress, thinking small scale investor is moving in. As price catalyzes, decrease share buying frequency to save money for the calls. Could easily end with >5% ownership, allowing more power in setting the future of CVM, either negotiating a higher acquisition price, or steering it towards becoming its own Pharmaceutical.
Why now?
Market is screwy, everyone is holding their breath waiting for this bomb, and the ending outcome is impossible to know 100%. Certain "safe" stocks are no longer safe, and the market is prone to a major shakeup everywhere. However, CVM is dirt cheap, but a safe bet. Cures for cancer are going to be at the head of hyperinflation, it is valuable forever. The drug cannot be outclassed by the "next wave" as the next wave of interleukin and cytokine therapies are pieces of Multikine, and any future medication that tears down the immunoblockade of tumours will only make Multikine work better.
This might just be the best inflation hedge right now, along with being sorely undervalued.
Disclaimer
I am not a financial anything, I am a biochemist/cancer researcher looking to live an easier life, and become an "activist investor".
This is a semi-anonymous sales pitch of a drug I am invested in, and believe will save a lot of lives from the horrors of cancer, and chemotherapy. I am available and willing to discuss this at any length in any details necessary, and have written several pieces on CVM.
Not financial advice, I don't know the future, and any interested party should perform their own due diligence before investing a single penny.
The Company
Cel Sci Corp is a small, Immunology based biotech with a small pipeline outside of Multikine.
41 million shares outstanding with only State Street, BlackRock and Vanguard having ~5% stakes.
Extremely oversold with massive short shares outstanding and a significant presence keeping the price down, meaning they will short sell into a large ownership percent (as they already have done with State Street).
Theoretical end market capitalization of $15+ billion, possibility for setting record; No need to rely on acquisition, company can be shifted towards manufacturing and sales while keeping research pipeline in place as manufacturing facility already built and owned by company.
Multikine
Mix of cytokines and interleukins in a proprietary mix that is injected into primary and secondary tumour sites to activate the immune system, capable of activating through some form of immunoblockade, but plenty of room for advancement with existing and next wave immunoblockade inhibitors.
No adverse reactions with drug.
Given pre-surgery.
Nothing unique to Head and Neck Cancer, thus creating a possible market in all solid tumours; metastatic cancers unknown, but possible depending on immune cells activated, possible mechanism similar to "cancer vaccines", but with self-made antigens.
Massive market with possible repeat dosing, likely route to becoming SOC or routine additional medicine to all existing cancer therapeutic strategies.
Cures cancer and saves lives (increased survival >5 years over existing surgery+radiation, likely better effect over Cisplatin meaning less cisplatin use as frontline).
Best Theoretical Plan
Calls are dirt cheap, and all strike prices are going to be in the money post-catalyst (either FDA news or large scale investor, aka you).
Buy all the calls, buy batches of shares, 10k in size with time to cool between cycles as shorts will continue to try to suppress, thinking small scale investor is moving in. As price catalyzes, decrease share buying frequency to save money for the calls. Could easily end with >5% ownership, allowing more power in setting the future of CVM, either negotiating a higher acquisition price, or steering it towards becoming its own Pharmaceutical.
Why now?
Market is screwy, everyone is holding their breath waiting for this bomb, and the ending outcome is impossible to know 100%. Certain "safe" stocks are no longer safe, and the market is prone to a major shakeup everywhere. However, CVM is dirt cheap, but a safe bet. Cures for cancer are going to be at the head of hyperinflation, it is valuable forever. The drug cannot be outclassed by the "next wave" as the next wave of interleukin and cytokine therapies are pieces of Multikine, and any future medication that tears down the immunoblockade of tumours will only make Multikine work better.
This might just be the best inflation hedge right now, along with being sorely undervalued.
Disclaimer
I am not a financial anything, I am a biochemist/cancer researcher looking to live an easier life, and become an "activist investor".
This is a semi-anonymous sales pitch of a drug I am invested in, and believe will save a lot of lives from the horrors of cancer, and chemotherapy. I am available and willing to discuss this at any length in any details necessary, and have written several pieces on CVM.
Not financial advice, I don't know the future, and any interested party should perform their own due diligence before investing a single penny.
